COVID-19合并肺栓塞:临床特征与心脏表现
单中心回顾性观察队列纳入2020年3月1日至4月30日住院的COVID-19患者,经CTPA确诊肺栓塞15例(中位年龄58岁,87%男性)。最常见症状为呼吸困难(67%)和发热(47%),80%入院前症状持续≥7天不缓解;47%需CPAP,其中13%后续插管。所有患者D-二聚体、LDH、CRP、铁蛋白及凝血酶原时间均显著升高;93%为外周或亚段肺栓塞,仅1例中央型;67%静息ECG异常(最常见窦性心动过速),40%接受TTE者右心结构和功能正常。作者提示TTE和ECG在此背景下对肺栓塞预测不可靠。
要点
- COVID-19患者急性恶化、病程迁延症状不缓解、呼吸困难加重或持续需氧时,应排查肺栓塞。
- D-二聚体显著升高是重要提示,本队列所有确诊肺栓塞患者D-二聚体均显著升高。
- 本队列93%(14/15)为外周或亚段肺栓塞,仅1例中央型,分布与CTPA实变模式相关(60%)。
- TTE不可靠:40%(6/15)接受TTE者右心结构和功能正常;ECG仅67%异常,最常见为窦性心动过速。
- 本队列病死率13%(2/15),均为>70岁男性。
适用人群与场景
- 2020年3月1日至4月30日住院的COVID-19患者(单中心),后续经CTPA确诊肺栓塞。
诊断标准与关键阈值
- 肺栓塞诊断依据:CTPA确诊。
- 原文未提及D-二聚体具体界值或其他评分阈值。
处置流程与药物剂量
- 原文未提及具体抗凝药物、剂量、给药途径或疗程。
- 原文提及7例(47%)需CPAP,其中2例(13%)后续插管,但未给出具体参数或流程。
红旗征与不能漏的情况
- 急性恶化、病程迁延伴症状不缓解、呼吸困难加重、持续需氧或D-二聚体显著升高者应排查肺栓塞(尤其COVID-19背景下)。
- >70岁男性患者死亡2例(13%),需关注。
研究设计与关键结果
- 单中心回顾性观察队列,15例COVID-19合并肺栓塞患者,中位年龄58岁(IQR 23),87%男性。
- 症状:呼吸困难67%(10/15),发热47%(7/15);80%(12/15)入院前症状持续≥7天不缓解。
- 呼吸支持:47%(7/15)需CPAP,其中13%(2/15)后续插管;病死率13%(2/15),均为>70岁男性。
- 实验室:所有患者D-二聚体、LDH、CRP、铁蛋白及凝血酶原时间均显著升高。
- 影像:93%(14/15)为外周或亚段肺栓塞,仅1例中央型;60%(9/15)肺栓塞分布与CTPA实变模式相关。
- 心脏评估:67%(10/15)静息ECG异常,最常见窦性心动过速;40%(6/15)接受TTE者右心结构和功能正常。
证据类型、等级与局限
- 证据类型:单中心、回顾性观察性队列研究(原文明确写 single centre, retrospective observational cohort study)。
- 局限性:原文未述局限性。
对床旁实践的改变
- 对COVID-19患者出现急性恶化、症状迁延不缓解、呼吸困难加重、持续需氧或D-二聚体显著升高时,应考虑行CTPA排查肺栓塞。
- 本队列以周围型/亚段肺栓塞为主(93%),阅读CTPA时需注意外周及亚段分支。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The thrombogenic potential of Covid-19 is increasingly recognised. We aim to assess the characteristics of COVID-19 patients diagnosed with pulmonary embolism (PE).
METHODS: We conducted a single centre, retrospective observational cohort study of COVID-19 patients admitted between 1st March and 30th April 2020 subsequently diagnosed with PE following computed tomography pulmonary angiogram (CTPA). Patient demographics, comorbidities, presenting complaints and inpatient investigations were recorded.
RESULTS: We identified 15 COVID-19 patients diagnosed with PE (median age = 58 years [IQR = 23], 87% male). 2 died (13%), both male patients >70 years. Most common symptoms were dyspnoea (N = 10, 67%) and fever (N = 7, 47%). 12 (80%) reported 7 days or more of non-resolving symptoms prior to admission. 7 (47%) required continuous positive airway pressure (CPAP), 2 (13%) of which were subsequently intubated. All patients had significantly raised D-dimer levels, lactate dehydrogenase (LDH), C-reactive protein (CRP), ferritin and prothrombin times. The distribution of PEs correlated with the pattern of consolidation observed on CTPA in 9 (60%) patients; the majority being peripheral or subsegmental (N = 14, 93%) and only 1 central PE. 10 (67%) had an abnormal resting electrocardiogram (ECG), the commonest finding being sinus tachycardia. 6 (40%) who underwent transthoracic echocardiography (TTE) had structurally and functionally normal right hearts.
CONCLUSION: Our study suggests that patients who demonstrate acute deterioration, a protracted course of illness with non-resolving symptoms, worsening dyspnoea, persistent oxygen requirements or significantly raised D-dimer levels should be investigated for PE, particularly in the context of COVID-19 infection. TTE and to a lesser degree the ECG are unreliable predictors of PE within this context.
参考来源
- Kho J, Ioannou A, Van den Abbeele K, et al. Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications. Am J Emerg Med. 2020. PMID: 33046316. doi:10.1016/j.ajem.2020.07.054
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。